Literature DB >> 4113490

Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver.

S N Huang, I Millman, A O'Connell, A Aronoff, H Gault, B S Blumberg.   

Abstract

IN A PREVIOUS REPORT (HUANG SN: Hepatitis-associated antigen hepatitis: an electron microscopic study. Am J Pathol 64:483-500, 1971) liver biopsies of renal transplant patients who developed chronic progressive viral hepatitis associated with persistence of Australia antigenemia [Au(1)] while under immunosuppressive therapy were studied. Predominantly intranuclear 210-250 A spherical, virus-like particles were revealed in 12 of 13 biopsies examined by electron microscope. No such particles were found in biopsies from Australia antigen negative patients. To investigate the relationship of these virus-like particles to Australia antigen, 2 of the Au(1) hepatitis renal transplant patients were restudied 6 to 8 months later. Liver biopsy material was prepared for light microscopy, immunofluorescent microscopy, electron microscopy and immunoelectron microscopy. The specificity of the anti-Au(1) serum used in this study was ascertained by immunodiffusion and immunoelectrophoresis, and by immunoelectron microscopic studies of the antigen-antibody complex prepared in vitro by mixing the ferritin-conjugated anti-Au(1) reagent with the purified Au(1) particles. Electron microscopy of biopsies from liver not treated with antibody showed that virus-like particles persisted in liver cells. Immunofluorescent microscopy of teased liver biopsy suspensions showed nuclear and some cytoplasmic fluorescence, indicating the cellular localization of Au(1). The immunoelectron microscopic preparations showed agglutination of the virus-like particles and the presence of antibody coupled ferritin in the intranuclear and cytoplasmic particle agglutinates. No virus-like particles were seen in the biopsy from a control patient without Au(1) antigenemia, and results of the immunoelectron microscopic procedure were negative. Our observations that massive amounts of Au(1)-associated particles are located in liver cell nuclei of individuals with chronic active hepatitis strengthen the hypothesis of Blumberg et al that Au(1) is an infectious agent and/or the antigenic determinant of a hepatitis virus.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4113490      PMCID: PMC2032745     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders.

Authors:  A Nowoslawski; W J Brzosko; K Madaliński; K Krawczyński
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

2.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

3.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

4.  Viral hepatitis. Revised concepts as a result of the study of Australia antigen.

Authors:  A I Sutnick; W T London; I Millman; V E Coyne; B S Blumberg
Journal:  Med Clin North Am       Date:  1970-05       Impact factor: 5.456

Review 5.  Australia antigen as a hepatitis virus. Variation in host response.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965

Review 6.  Australia antigen and hepatitis.

Authors:  B S Blumberg; A I Sutnick; W T London; I Millman
Journal:  N Engl J Med       Date:  1970-08-13       Impact factor: 91.245

7.  Australia antigen and hepatitis. An electron microscopic study.

Authors:  M N Ahmed; S Huang; L Spence
Journal:  Arch Pathol       Date:  1971-07

8.  Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic.

Authors:  I Millman; V Zavatone; B J Gerstley; B S Blumberg
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

9.  Association of virus-like particles with Australia antigen in serum of patients with serum hepatitis.

Authors:  E Zalan; J J Hamvas; B A Tobe; O Kuderewko; N A Labzoffsky
Journal:  Can Med Assoc J       Date:  1971-01-23       Impact factor: 8.262

10.  RNA of Australia antigen.

Authors:  W Józwiak; J Koscielak; K Madaliński; W J Brzosko; A Nowoslawski; M Kloczewiak
Journal:  Nat New Biol       Date:  1971-01-20
View more
  15 in total

1.  Immunosuppressive therapy and virus-cores in HBAg-positive chronic hepatitis.

Authors:  G Kendrey; A Szalka; B László; L Binder; I Hollós
Journal:  Klin Wochenschr       Date:  1975-11-15

2.  Hepatitis-associated antigen in immunofluorescence. I. Interfering factors.

Authors:  M D Beccati; G Fabris; I Nenci
Journal:  Histochem J       Date:  1974-11

3.  Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes.

Authors:  M A Gerber; S Hadziyannis; C Vissoulis; F Schaffner; F Paronetto; H Popper
Journal:  Am J Pathol       Date:  1974-06       Impact factor: 4.307

4.  Transplacental induction of membranous nephropathy in a neonate.

Authors:  J Nauta; E de Heer; W M Baldwin; F J ten Kate; A J v d Heijden; E D Wolff
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 5.  The immunopathology of acute type B hepatitis.

Authors:  L Bianchi
Journal:  Springer Semin Immunopathol       Date:  1981-04

Review 6.  Serology and epidemiology.

Authors:  J H Walsh
Journal:  West J Med       Date:  1975-09

7.  Arthritis and hepatitis.

Authors:  R T Mirise; R C Kitridou
Journal:  West J Med       Date:  1979-01

8.  Detection of Australia antigen in liver biopsies by immunofluorescence.

Authors:  G Cérat; G Richer; A Viallet; J Côté; J Robert; F Turgeon
Journal:  Can Med Assoc J       Date:  1973-04-21       Impact factor: 8.262

9.  Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees.

Authors:  A E Denes; J W Ebert; K R Berquist; B L Murphy; J E Maynard
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  Isolation of a murine hepatitis virus from Swiss mice treated with antilymphocyte serum.

Authors:  F de S van der Riet; L B Kahn
Journal:  Arch Gesamte Virusforsch       Date:  1973
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.